• Title of article

    Toxicity of nanomaterials; an undermined issue

  • Author/Authors

    Mogharabi, Mehdi tehran university of medical sciences tums - Faculty of Pharmacy Biotechnology Research Center, Faculty of Pharmacy and Pharmaceutical Sciences Research Center - Department of Pharmaceutical Biotechnology, Department of Toxicology and Pharmacology, تهران, ايران , Abdollahi, Mohammad tehran university of medical sciences tums - Faculty of Pharmacy and Pharmaceutical Sciences Research Center - Department of Toxicology and Pharmacology, تهران, ايران , Faramarzi, Mohammad Ali tehran university of medical sciences tums - Faculty of Pharmacy Biotechnology Research Center, Faculty of Pharmacy and Pharmaceutical Sciences Research Center - Department of Pharmaceutical Biotechnology, Department of Toxicology and Pharmacology, تهران, ايران

  • From page
    1
  • To page
    4
  • Abstract
    Nanomaterials are employed in extensive variety of commercial products such as electronic components, cosmetics, food, sports equipment, biomedical applications, and medicine. With the increasing utilization of engineered nanomaterials, the potential exposure of human to nanoparticles is rapidly increasing. Nowadays when new nanomaterials with new applications are introduced, mostly good and positive effects are mentioned whereas possible hazards arising from nanosize of the compounds are undermined. Toxicology studies of nanomaterials demonstrate some adverse effects in some human organs such as central nerve system, immune system, and lung. There is lack of complete information about human toxicity and environmental waste of nanomaterials. We aimed to highlight current toxicological concerns of potentially useful nanomaterials which are now used in pharmaceutical and biomedical sciences.
  • Keywords
    Adverse health effects , Drug delivery , Nanomaterials , Nanomedicine , Toxicity
  • Journal title
    Daru Journal of Pharmaceutical Sciences
  • Journal title
    Daru Journal of Pharmaceutical Sciences
  • Record number

    2634864